This clinical randomized controlled study is to explore the effect of positive airway pressure(PAP) on patients in Beijing Tsinghua Changgung Hospital diagnosed with both idiopathic sudden sensorineural hearing loss comorbided(ISSHL) and obstructive sleep apnea(OSA) between Dec. 2019 to Dec. 2029.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
102
non-invasive positive airway pressure is the first-line treatment for obstructive sleep apnea
Methylprednisolone is the first-line treatment of idiopathic sudden sensorineural hearing loss
ginnaton is ginkgo biloba extract
Beijing Tsinhgua Changgung Hospital
Beijing, Beijing Municipality, China
RECRUITINGhearing threshold
the recovery of hearing threshold which will be measured by pure tone audiometry
Time frame: 3 months after onset of ISSHL
Haijin Yi, MD
CONTACT
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.